Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC

NCT05541445 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Pembrolizumab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences